why choose us

First received: October 10, 2022

Clinical Trial: Expanding Medication-Assisted Therapies in Central Asia

Study Status: Completed

Recruit Status: RECRUITING

Condition: Opioid Use Disorder

Study Type: INTERVENTIONAL


Official Title: Expanding Medication-Assisted Therapies in Central Asia

Brief Summary: Central Asia (CA) represents the most rapidly growing HIV epidemic region worldwide, concentrated in people who inject drugs (PWID) and their sexual partners, and scaling up opioid agonist therapies (OAT) in this region is the most cost-effective strategy to prevent new HIV infections, and more effective when combined with antiretroviral therapy (ART).The investigators propose to use the Network for the Improvement of Addiction Treatment (NIATx) implementation strategy to scale-up OAT in three diverse Central…

Read more